| Company Name: |
J & K SCIENTIFIC LTD.
|
| Tel: |
010-82848833 400-666-7788 |
| Email: |
jkinfo@jkchemical.com |
| Products Intro: |
Product Name:4-AMino-6-chloro-1-β-D-ribofuranosyliMidazo[4,5-c]pyridine
CAS:40656-71-1
Package:50Mg,5Mg
|
4-Amino-6-chloro-1--D-ribofuranosylimidazo[4,5-c]pyridine manufacturers
|
| | 4-Amino-6-chloro-1--D-ribofuranosylimidazo[4,5-c]pyridine Basic information |
| Product Name: | 4-Amino-6-chloro-1--D-ribofuranosylimidazo[4,5-c]pyridine | | Synonyms: | 4-Amino-6-chloro-1--D-ribofuranosylimidazo[4,5-c]pyridine;6-Amino-2-chloro-9-(b-D-ribofuranosyl)purine;2-chloro-3-Deazaadenosine;6-Chloro-1-β-D-ribofuranosyl-1H-iMidazo[4,5-c]pyridin-4-aMine;NSC 158900;(2R,3R,4S,5R)-2-(4-amino-6-chloro-1H-imidazo[4,5-c]pyridin-1-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol;(2R,4R,5R)-2-(4-amino-6-chloroimidazo[4,5-c]pyridin-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol;1H-Imidazo[4,5-c]pyridin-4-amine, 6-chloro-1-β-D-ribofuranosyl- | | CAS: | 40656-71-1 | | MF: | C11H13ClN4O4 | | MW: | 300.7 | | EINECS: | | | Product Categories: | Nucleotides, Bases & Related Reagents;Bases & Related Reagents;Nucleotides | | Mol File: | 40656-71-1.mol | ![4-Amino-6-chloro-1--D-ribofuranosylimidazo[4,5-c]pyridine Structure](CAS2/GIF/40656-71-1.gif) |
| | 4-Amino-6-chloro-1--D-ribofuranosylimidazo[4,5-c]pyridine Chemical Properties |
| Melting point | 223-225°C | | Boiling point | 694.6±65.0 °C(Predicted) | | density | 2.02±0.1 g/cm3(Predicted) | | storage temp. | Refrigerator | | solubility | DMSO, Methanol | | form | Solid | | pka | 13.18±0.70(Predicted) | | color | Off-White to Beige |
| | 4-Amino-6-chloro-1--D-ribofuranosylimidazo[4,5-c]pyridine Usage And Synthesis |
| Chemical Properties | Off-White Solid | | Uses | Adenosine analog | | Biological Activity | 2-chloro-3-deazaadenosine, a stable analog of adenosine, is an agonist for adenosine receptors [1].adenosine receptors are members of g-protein-coupled receptors (gpcrs). extracellular adenosine acts as a local modulator with a generally cytoprotective function in the body. extracellular adenosine has been implicated in increasing the ratio of oxygen supply to demand, protecting against ischaemic damage by cell conditioning, triggering anti-inflammatory responses and the promotion of angiogenesis [2]. | | in vitro | the ki values of 2-chloro-3-deazaadenosine for a1, a2a, a2b, and a3 receptors were 0.3, 0.08, 25.5, and 1.9 μm, respectively [1]. 2-chloroadenosine (25 μm) increased activity of platelet adenylate cyclase to about 150–160% of the control value. higher concentrations of 2-chloroadenosine showed less effect above 100 μm [3]. | | in vivo | in the rat with delayed ischaemic damage, iterative focal injections of 2-chloroadenosine protected against selective hippocampal ca1 loss [4]. | | references | [1] linden j, thai t, figler h, et al. characterization of human a2b adenosine receptors: radioligand binding, western blotting, and coupling to gqin human embryonic kidney 293 cells and hmc-1 mast cells[j]. molecular pharmacology, 1999, 56(4): 705-713.
[2] jacobson k a, gao z g. adenosine receptors as therapeutic targets[j]. nature reviews drug discovery, 2006, 5(3): 247-264.
[3] haslam r j, lynham j a. activation and inhibition of blood platelet adenylate cyclase by adenosine or by 2-chloroadenosine[j]. life sciences, 1972, 11(23): 1143-1154.
[4] evans m c, swan j h, meldrum b s. an adenosine analogue, 2-chloroadenosine, protects against long term development of ischaemic cell loss in the rat hippocampus[j]. neuroscience letters, 1987, 83(3): 287-292. |
| | 4-Amino-6-chloro-1--D-ribofuranosylimidazo[4,5-c]pyridine Preparation Products And Raw materials |
|